Sells rehabilitation equipment and orthopedic braces to clinicians, clinics, and hospitals.
10-K for FY2025, filed Oct 14, 2025We offer a broad range of restorative products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and…View ↗
Our products are used primarily by orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners…View ↗
We sell products to licensed practitioners such as orthopedists, physical therapists, chiropractors, and athletic trainers. Our customers…View ↗
Customers pay for products when the goods ship or are delivered, depending on the shipping terms. Rebates and discounts can reduce the amount the company receives.
10-K for FY2025, filed Oct 14, 2025Revenue RecognitionView ↗
10-K for FY2025, filed Oct 14, 2025
FY2025 revenue by product or service ↗$27.4M
10-K for FY2025, filed Oct 14, 2025
$27.4M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Physical Therapy and Rehabilitation Products
Sold outright
10-K for FY2025, filed Oct 14, 2025 |
55%
FY2022: 52%
|
Physical Therapy and Rehabilitation Products, FY2025
$15.2M Sources
|
Sold outright |
|
Orthopedic Soft Bracing Products
Sold outright
10-K for FY2025, filed Oct 14, 2025 |
44%
FY2022: 47%
|
Orthopedic Soft Bracing Products, FY2025
$12.1M Sources
|
Sold outright |
|
Other Products
Sold outright
|
0.3%
FY2022: 0.2%
|
Other Products, FY2025
$94.2K Sources
|
Sold outright |
Licensed practitioners, sports teams and universities, care facilities, hospitals, clinics, distributors, and equipment makers buy the products. Dealers typically buy and resell them to end users; the company also sells directly to clinics, hospitals, and purchasing groups, using independent and direct sales representatives.
10-K for FY2025, filed Oct 14, 2025
Not on paper. It lost $10.9M in FY2025, but brought in more cash than it spent: $270.1K of free cash flow.
10-K for FY2025, filed Oct 14, 2025
−$2.5MView ↗
10-K for FY2025, filed Oct 14, 2025
−$10.9MView ↗
10-K for FY2025, filed Oct 14, 2025
$270.1KView ↗
10-Q for Q1 FY2026, filed Nov 19, 2025
−$201.9KView ↗
10-Q for Q1 FY2026, filed Nov 19, 2025
Open tableView ↗
8-K, filed Jan 12, 2026
On January 9, 2026, after considering all strategic alternatives, Dynatronics Corporation (the "Company"), and its wholly-owned…View ↗
Shrinking. Revenue fell 43% in 4 years, from $47.8M in FY2021 to $27.4M in FY2025, about 13% a year.
Loading...